Cardiome Pharma Corp (NASDAQ:CRME)

9.11
Delayed Data
As of Jul 02
 +0.06 / +0.66%
Today’s Change
5.84
Today|||52-Week Range
11.31
-1.51%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues7.7M7.8M7.0M5.5M
 
 
 
 
 
Cost of Goods Sold2.2M2.7M3.6M1.2M
 
 
 
 
 
Depreciation And Amortization564.0K510.0K540.0K541.0K
 
 
 
 
 
 
Operating ExpensesGross Income4.9M4.6M2.8M3.7M
 
 
 
 
 
General Expenses8.9M8.1M9.2M6.4M
 
 
 
 
 
Research And Development59.0K234.0K99.0K62.0K
 
 
 
 
 
Total Operating Expenses11.7M11.3M13.4M8.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.0M-3.5M-6.4M-2.7M
 
 
 
 
 
Interest Expense On Debt226.0K495.0K508.0K674.0K
 
 
 
 
 
Other Expenses149.0K-285.0K108.0K-449.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.1M-4.3M-6.8M-3.8M
 
 
 
 
 
Income Taxes-156.0K-114.0K-338.0K-107.0K
 
 
 
 
 
Net Income-4.2M-4.4M-6.5M-3.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS16.5M16.5M16.2M16.7M
 
 
 
 
 
Shares To Calculate EPS Diluted16.5M16.5M16.2M16.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.26-$0.26-$1.12-$0.23
 
 
 
 
 
EPS Diluted-$0.26-$0.26-$0.39-$0.23
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account